News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Solexa Ltd. (SLXA) Granted European Patent On Use Of Single Molecules For Sequencing


2/2/2006 3:53:43 PM

Solexa, Inc. (Nasdaq:SLXA) today announced that the European Patent Office has granted the company a key patent covering the use of single molecules for DNA analysis. This granted patent, EP1105529B1, further strengthens Solexa's intellectual property (IP) portfolio, which consists of some of the earliest and most fundamental patents and applications addressing the use of both single molecules and amplified colonies of single molecules for genetic analysis applications, including DNA sequencing and gene expression analysis.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES